| Thiazolidinediones and blood lipids in type 2 diabetes. | |
| | |
MedLine Citation:
|
PMID: 12907465 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We evaluated study population characteristics and treatment effects on blood lipids between studies in which either rosiglitazone (RSG) or pioglitazone (PIO) was investigated in patients with type 2 diabetes. We performed a summary analysis of all published double-blind, placebo-controlled studies with RSG (4 and 8 mg/d) and PIO (15, 30, and 45 mg/d). Data were analyzed by the random-effects model. Nineteen trials met our inclusion criteria, yielding 5304 patients, 3236 in studies with RSG and 2068 in studies with PIO. Subjects treated with PIO were more obese and showed more pronounced hyperglycemia and dyslipidemia (increased triglycerides and decreased HDL cholesterol) at baseline than did subjects treated with RSG. By weighted linear-regression analysis, studies with PIO showed greater beneficial effects on triglycerides, total cholesterol, and LDL cholesterol, after adjustment for the respective lipid levels at baseline. RSG 8 mg/d showed greater increases in total cholesterol and LDL cholesterol than did RSG 4 mg/d. PIO 30 mg/d showed greater reductions in triglycerides than did PIO 15 mg/d. Studies conducted with PIO showed more beneficial effects on blood lipids, but also different study population characteristics in comparison with studies conducted with RSG. Differences in both pharmacologic properties between agents and study population characteristics are likely to have influenced the results. |
| | |
Authors:
|
Jeroen P H van Wijk; Eelco J P de Koning; Edwin P Martens; Ton J Rabelink |
Related Documents
:
|
2294675 - Dyslipidemias with desirable plasma total cholesterol levels and angiographically demon... 14676595 - Serum lipids in preterm infants fed a formula supplemented with nucleotides. 20609185 - Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis pat... 15238825 - The effects of lipid-lowering therapy on paraoxonase activities and their relationships... 9161465 - Effect of the type of dietary fat on cholesterolemia in rabbits fed brewer's yeast. 15182405 - Diet, serum homocysteine levels and ischaemic heart disease in a mediterranean population. |
Publication Detail:
|
Type: Journal Article; Meta-Analysis Date: 2003-08-07 |
Journal Detail:
|
Title: Arteriosclerosis, thrombosis, and vascular biology Volume: 23 ISSN: 1524-4636 ISO Abbreviation: Arterioscler. Thromb. Vasc. Biol. Publication Date: 2003 Oct |
Date Detail:
|
Created Date: 2003-10-13 Completed Date: 2004-02-25 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 9505803 Medline TA: Arterioscler Thromb Vasc Biol Country: United States |
Other Details:
|
Languages: eng Pagination: 1744-9 Citation Subset: IM |
Affiliation:
|
Department of Vascular Medicine, University Medical Center, University of Utrecht, Utrecht, the Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cholesterol
/
blood* Diabetes Mellitus, Type 2 / blood, drug therapy* Drug Therapy, Combination Humans Hypoglycemic Agents / pharmacology, therapeutic use* Linear Models Thiazolidinediones / pharmacology, therapeutic use* Triglycerides / blood* |
| Chemical | |
Reg. No./Substance:
|
0/Hypoglycemic Agents; 0/Thiazolidinediones; 0/Triglycerides; 111025-46-8/pioglitazone; 122320-73-4/rosiglitazone; 57-88-5/Cholesterol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ethanol inhibits fibroblast growth factor-induced proliferation of aortic smooth muscle cells.
Next Document: An in vivo experimental system to study sugar phloem unloading in ripening grape berries during wate...